Impact of COVID-19 in Children with Chronic Lung Diseases
Abstract
:1. Introduction
2. Materials and Methods
3. Children with CLD and Risk for Severe COVID-19
4. How CLD Could Affect the Risk of SARS-CoV-2 Infection
5. Children with CLD and Organization of Patient Care during COVID-19 Pandemic
6. Children with CLD and Psychosocial Impact of COVID-19 Pandemic
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Shen, K.L.; Yang, Y.H.; Jiang, R.M.; Wang, T.Y.; Zhao, D.C.; Jiang, Y.; Lu, X.X.; Jin, R.M.; Zheng, Y.J.; Xu, B.P.; et al. Updated diagnosis, treatment and prevention of COVID-19 in children: Experts’ consensus statement (condensed version of the second edition). World J. Pediatr. 2020, 16, 232–239. [Google Scholar] [CrossRef] [PubMed]
- Girona-Alarcon, M.; on behalf of the KIDS-Corona study group; Bobillo-Perez, S.; Sole-Ribalta, A.; Hernandez, L.; Guitart, C.; Suarez, R.; Balaguer, M.; Cambra, F.-J.; Jordan, I.; et al. The different manifestations of COVID-19 in adults and children: A cohort study in an intensive care unit. BMC Infect. Dis. 2021, 21, 87. [Google Scholar] [CrossRef] [PubMed]
- Parri, N.; Lenge, M.; Buonsenso, D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with COVID-19 in Pediatric Emergency Departments in Italy. N. Engl. J. Med. 2020, 383, 187–190. [Google Scholar] [CrossRef] [PubMed]
- Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y.Y.; Qu, J.; Zhang, W.; Wang, Y.; Bao, S.; Li, Y.; et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020, 382, 1663–1665. [Google Scholar] [CrossRef] [PubMed]
- Panaro, S.; Cattalini, M. The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn from Multisystem Inflammatory Syndrome in Children (MIS-C). Front. Med. 2021, 8, 747190. [Google Scholar] [CrossRef]
- Spinelli, M.; Lionetti, F.; Pastore, M.; Fasolo, M. Parents’ Stress and Children’s Psychological Problems in Families Facing the COVID-19 Outbreak in Italy. Front. Psychol. 2020, 11, 1713. [Google Scholar] [CrossRef]
- Götzinger, F.; Santiago-García, B.; Noguera-Julián, A.; Lanaspa, M.; Lancella, L.; Carducci, F.I.C.; Gabrovska, N.; Velizarova, S.; Prunk, P.; Osterman, V.; et al. COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc. Health 2020, 4, 653–661. [Google Scholar] [CrossRef]
- Bellino, S.; Punzo, O.; Rota, M.C.; Del Manso, M.; Urdiales, A.M.; Andrianou, X.; Fabiani, M.; Boros, S.; Vescio, F.; Riccardo, F.; et al. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy. Pediatrics 2020, 146, e2020009399. [Google Scholar] [CrossRef]
- Kompaniyets, L.; Agathis, N.T.; Nelson, J.M.; Preston, L.E.; Ko, J.Y.; Belay, B.; Pennington, A.F.; Danielson, M.L.; DeSisto, C.L.; Chevinsky, J.R.; et al. Underlying Medical Conditions Associated with Severe COVID-19 Illness Among Children. JAMA Netw. Open 2021, 4, e2111182. [Google Scholar] [CrossRef]
- Moeller, A.; Thanikkel, L.; Duijts, L.; Gaillard, E.A.; Garcia-Marcos, L.; Kantar, A.; Tabin, N.; Turner, S.; Zacharasiewicz, A.; Pijnenburg, M.W. COVID-19 in children with underlying chronic respiratory diseases: Survey results from 174 centres. ERJ Open Res. 2020, 6, 00409–2020. [Google Scholar] [CrossRef]
- Papadopoulos, N.G.; Mathioudakis, A.G.; Custovic, A.; Deschildre, A.; Phipatanakul, W.; Wong, G.; Xepapadaki, P.; Abou-Taam, R.; Agache, I.; Castro-Rodriguez, J.A.; et al. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. Allergy 2021, 76, 1765–1775. [Google Scholar] [CrossRef] [PubMed]
- Rao, S.; Hurst, J.H.; Zhao, C.; Goldstein, B.A.; Thomas, L.; Lang, J.E.; Kelly, M.S. Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents. Pediatrics 2022, 149, e2021056164. [Google Scholar] [CrossRef] [PubMed]
- Shi, T.; Pan, J.; Katikireddi, S.V.; McCowan, C.; Kerr, S.; Agrawal, U.; Shah, S.A.; Simpson, C.R.; Ritchie, L.D.; Robertson, C.; et al. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: A national incident cohort study. Lancet Respir. Med. 2022, 10, 191–198. [Google Scholar] [CrossRef]
- Pedersen, E.S.; Goutaki, M.; Harris, A.L.; Dixon, L.; Manion, M.; Rindlisbacher, B.; Lucas, J.S.; Kuehni, C.E. SARS-CoV-2 infections in people with primary ciliary dyskinesia: Neither frequent, nor particularly severe. Eur. Respir. J. 2021, 58, 2004548. [Google Scholar] [CrossRef]
- Bain, R.; Cosgriff, R.; Zampoli, M.; Elbert, A.; Burgel, P.R.; Carr, S.B.; Castaños, C.; Colombo, C.; Corvol, H.; Faro, A.; et al. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study. J. Cyst. Fibros. 2021, 20, 25–30. [Google Scholar] [CrossRef]
- Corvol, H.; De Miranda, S.; Lemonnier, L.; Kemgang, A.; Gaubert, M.R.; Chiron, R.; Dalphin, M.-L.; Durieu, I.; Dubus, J.-C.; Houdouin, V.; et al. First Wave of COVID-19 in French Patients with Cystic Fibrosis. J. Clin. Med. 2020, 9, 3624. [Google Scholar] [CrossRef]
- Dasenbrook, E. Keep cystic fibrosis patients out of the hospital. Clevel. Clin. J. Med. 2020. [Google Scholar] [CrossRef]
- Colombo, C.; Burgel, P.-R.; Gartner, S.; van Koningsbruggen-Rietschel, S.; Naehrlich, L.; Sermet-Gaudelus, I.; Southern, K.W. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir. Med. 2020, 8, e35–e36. [Google Scholar] [CrossRef]
- Davies, J.M.; Carroll, M.L.; Li, H.; Poh, A.M.; Kirkegard, D.; Towers, M.; Upham, J.W. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS ONE 2011, 6, e27898. [Google Scholar] [CrossRef]
- Yamaya, M.; Nishimura, H.; Deng, X.; Sugawara, M.; Watanabe, O.; Nomura, K.; Shimotai, Y.; Momma, H.; Ichinose, M.; Kawase, T. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020, 58, 155–168. [Google Scholar] [CrossRef]
- Peters, M.C.; Sajuthi, S.; DeFord, P.; Christenson, S.; Rios, C.L.; Montgomery, M.T.; Woodruff, P.G.; Mauger, D.T.; Erzurum, S.C.; Johansson, M.W.; et al. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. Am. J. Respir. Crit. Care Med. 2020, 202, 83–90. [Google Scholar] [CrossRef] [PubMed]
- Ramakrishnan, S.; Nicolau, D.V.; Langford, B.; Mahdi, M.; Jeffers, H.; Mwasuku, C.; Krassowska, K.; Fox, R.; Binnian, I.; Glover, V.; et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir. Med. 2021, 9, 763–772. [Google Scholar] [CrossRef]
- Yu, L.-M.; Bafadhel, M.; Dorward, J.; Hayward, G.; Saville, B.R.; Gbinigie, O.; Van Hecke, O.; Ogburn, E.; Evans, P.H.; Thomas, N.P.B.; et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet 2021, 398, 843–855. [Google Scholar] [CrossRef]
- Schultze, A.; Walker, A.J.; MacKenna, B.; Morton, C.E.; Bhaskaran, K.; Brown, J.P.; Rentsch, C.T.; Williamson, E.; Drysdale, H.; Croker, R.; et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: An observational cohort study using the OpenSAFELY platform. Lancet Respir. Med. 2020, 8, 1106–1120. [Google Scholar] [CrossRef]
- Halpin, D.M.G.; Singh, D.; Hadfield, R.M. Inhaled corticosteroids and COVID-19: A systematic review and clinical perspective. Eur. Respir. J. 2020, 55, 2001009. [Google Scholar] [CrossRef]
- Jackson, D.J.; Busse, W.W.; Bacharier, L.B.; Kattan, M.; O’Connor, G.T.; Wood, R.A.; Visness, C.M.; Durham, S.R.; Larson, D.; Esnault, S.; et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020, 146, 203–206.e3. [Google Scholar] [CrossRef] [PubMed]
- Sajuthi, S.P.; DeFord, P.; Jackson, N.D.; Montgomery, M.T.; Everman, J.L.; Rios, C.L.; Pruesse, E.; Nolin, J.D.; Plender, E.G.; Wechsler, M.E.; et al. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium. bioRxiv 2020. [Google Scholar] [CrossRef]
- Du, H.; Dong, X.; Zhang, J.; Cao, Y.; Akdis, M.; Huang, P.; Chen, H.; Li, Y.; Liu, G.; Akdis, C.A.; et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy 2021, 76, 510–532. [Google Scholar] [CrossRef]
- Papadopoulos, N.G.; Custovic, A.; Deschildre, A.; Mathioudakis, A.G.; Phipatanakul, W.; Wong, G.; Xepapadaki, P.; Agache, I.; Bacharier, L.; Bonini, M.; et al. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J. Allergy Clin. Immunol. Pract. 2020, 8, 2592–2599.e3. [Google Scholar] [CrossRef] [PubMed]
- Lubrano, R.; Villani, A.; Berrettini, S.; Caione, P.; Chiara, A.; Costantino, A.; Formigari, R.; Franzoni, E.; Gattinara, G.C.; Giustardi, A.; et al. Point of view of the Italians pediatric scientific societies about the pediatric care during the COVID-19 lockdown: What has changed and future prospects for restarting. Ital. J. Pediatr. 2020, 46, 142. [Google Scholar] [CrossRef] [PubMed]
- Nayir Buyuksahin, H.; Emiralioglu, N.; Ademhan Tural, D.; Ozsezen, B.; Sunman, B.; Guzelkas, I.; Yalcin, E.; Dogru, D.; Ozcelik, U.; Kiper, N. Impact of COVID-19 on pediatric pulmonology healthcare practice. Pediatr. Pulmonol. 2021, 56, 2811–2817. [Google Scholar] [CrossRef] [PubMed]
- Bignamini, E.; Cazzato, S.; Cutrera, R.; Ferrante, G.; La Grutta, S.; Licari, A.; Lombardi, E.; Midulla, F.; Piacentini, G.; Pifferi, M.; et al. Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic. Ital. J. Pediatr. 2020, 46, 68. [Google Scholar] [CrossRef] [PubMed]
- Esposito, S.; Parma COVID-19 Pediatric Working Group (PaCoPed); Voccia, E.; Cantarelli, A.; Canali, A.; Principi, N.; Prati, A. Telemedicine for management of paediatric infectious diseases during COVID-19 outbreak. J. Clin. Virol. 2020, 129, 104522. [Google Scholar] [CrossRef] [PubMed]
- Gilbert, A.W.; Billany, J.C.; Adam, R.; Martin, L.; Tobin, R.; Bagdai, S.; Galvin, N.; Farr, I.; Allain, A.; Davies, L.; et al. Rapid implementation of virtual clinics due to COVID-19: Report and early evaluation of a quality improvement initiative. BMJ Open Qual. 2020, 9, e000985. [Google Scholar] [CrossRef]
- Liu, S.; Yang, L.; Zhang, C.; Xiang, Y.T.; Liu, Z.; Hu, S.; Zhang, B. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 2020, 7, e17–e18. [Google Scholar] [CrossRef]
- Hatziagorou, E.; Toulia, I.; Avramidou, V.; Kampouras, A.; Tsara, V.; Tsanakas, J. Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting. Pediatr. Pulmonol. 2021, 56, 3065–3067. [Google Scholar] [CrossRef]
- Gifford, A.H.; Ong, T.; Dowd, C.; Van Citters, A.D.; Scalia, P.; Sabadosa, K.A.; Sawicki, G.S. Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs. J. Cyst. Fibros. 2021, 20 (Suppl. 3), 9–13. [Google Scholar] [CrossRef]
- Wang, Y.; Di, Y.; Ye, J.; Wei, W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol. Health Med. 2021, 26, 13–22. [Google Scholar] [CrossRef]
- Çölkesen, F.; Kılınçel, O.; Sözen, M.; Yıldız, E.; Beyaz, Ş.; Çölkesen, F.; Aytekin, G.; Koçak, M.Z.; Alsancak, Y.; Araz, M.; et al. The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Asthma Allergy Immunol. 2021, 19, 84–91. [Google Scholar] [CrossRef]
- Di Riso, D.; Spaggiari, S.; Cambrisi, E.; Ferraro, V.; Carraro, S.; Zanconato, S. Psychosocial impact of COVID-19 outbreak on Italian asthmatic children and their mothers in a post lockdown scenario. Sci. Rep. 2021, 11, 9152. [Google Scholar] [CrossRef]
- Lazzerini, M.; Barbi, E.; Apicella, A.; Marchetti, F.; Cardinale, F.; Trobia, G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc. Health 2020, 4, e10–e11. [Google Scholar] [CrossRef]
- Abrams, E.M.; McGill, G.; Bhopal, S.S.; Sinha, I.; Fernandes, R.M. COVID-19, asthma, and return to school. Lancet Respir. Med. 2020, 8, 847–849. [Google Scholar] [CrossRef]
- Riccio, M.P.; Borrelli, M.; Fioretti, M.T.; Del Bene, M.; Bravaccio, C.; Poeta, M.; Santamaria, F. Is Quarantine for COVID-19 Pandemic Associated with Psychological Burden in Primary Ciliary Dyskinesia? Int. J. Environ. Res. Public Health 2020, 17, 8099. [Google Scholar] [CrossRef] [PubMed]
- Graziano, S.; Boldrini, F.; Quittner, A.L.; Fiocchi, A.G.; Tabarini, P. Stress and mental health in adolescents and young adults with cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample. Pediatr. Pulmonol. 2022. [Google Scholar] [CrossRef]
- Dong, H.; Yang, F.; Lu, X.; Hao, W. Internet Addiction and Related Psychological Factors among Children and Adolescents in China During the Coronavirus Disease 2019 (COVID-19) Epidemic. Front. Psychiatry 2020, 11, 00751. [Google Scholar] [CrossRef]
- Sismanlar Eyuboglu, T.; Aslan, A.T.; Ramaslı Gursoy, T.; Asfuroglu, P.; Soysal, A.S.; Yapar, D.; İlhan, M.N. Sleep disturbances in children with cystic fibrosis, primary ciliary dyskinesia and typically developing children during COVID-19 pandemic. J. Paediatr. Child Health 2021, 57, 1605–1611. [Google Scholar] [CrossRef]
- Marciano, L.; Ostroumova, M.; Schulz, P.J.; Camerini, A.-L. Digital Media Use and Adolescents’ Mental Health during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Front. Public Health 2021, 9, 793868. [Google Scholar] [CrossRef]
- Zorcec, T.; Jakovska, T.; Micevska, V.; Boskovska, K.; Cholakovska, V.C. Pandemic with COVID-19 and Families with Children with Chronic Respiratory Diseases. Prilozi 2020, 41, 95–101. [Google Scholar] [CrossRef]
- Torres-Castro, R.; Vasconcello-Castillo, L.; Acosta-Dighero, R.; Sepúlveda-Cáceres, N.; Barros-Poblete, M.; Puppo, H.; Vera-Uribe, R.; Vilaró, J.; Herrera-Romero, M. Physical Activity in Children and Adolescents with Chronic Respiratory Diseases: A Systematic Review and Meta-Analysis. J. Phys. Act. Health 2021, 18, 219–229. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ferraro, V.A.; Zanconato, S.; Carraro, S. Impact of COVID-19 in Children with Chronic Lung Diseases. Int. J. Environ. Res. Public Health 2022, 19, 11483. https://doi.org/10.3390/ijerph191811483
Ferraro VA, Zanconato S, Carraro S. Impact of COVID-19 in Children with Chronic Lung Diseases. International Journal of Environmental Research and Public Health. 2022; 19(18):11483. https://doi.org/10.3390/ijerph191811483
Chicago/Turabian StyleFerraro, Valentina Agnese, Stefania Zanconato, and Silvia Carraro. 2022. "Impact of COVID-19 in Children with Chronic Lung Diseases" International Journal of Environmental Research and Public Health 19, no. 18: 11483. https://doi.org/10.3390/ijerph191811483